News

Job Opening: Policy Analysis Consultant, National Viral Hepatitis Roundtable

E-mail Print
SEP-15-11 The National Viral Hepatitis Roundtable seeks a Policy Analyst consultant located in Washington, D.C. The position is open immediately until filled.
Read more »
 

In Mourning

E-mail Print
Red RibbonWe at the Forum for Collaborative HIV Research deeply mourn the deaths of all of the 298 persons on Malaysian Airlines flight MH17, among them many individuals traveling to the International AIDS Conference in Melbourne. There are no words to adequately describe the loss to the field caused by this shocking and horrifying event. An International AIDS Conference without Joep Lange is unimaginable – made even sadder because this new reality is forever. Together with the global AIDS community, we grieve the loss of this exceptional leader, colleague, mentor and collaborator. We remember the ceaselessness and tirelessness of his commitment to ensure treatment of all people no matter who or where, his persistence in pushing the envelope of regional and global policy, and his insistence on the utmost rigorous science and impatience and intolerance of anything but.  Most of all, we remember his human side – honest, direct, often blunt but always caring friend to many of us.  Our sincerest condolences to family and friends of Joep Lange, Jacqueline van Tongeren and the other victims of the crash. 
 

Treatment Action Group: Pills Cost Pennies, Greed Costs Lives: 1st HCV World Community Advisory Board Meeting Report

E-mail Print
On February 22-25, 2014, the Treatment Action Group and the Asia Pacific Network of People Living with HIV/AIDS convened the 1st HCV World Community Advisory Group meeting to provide a forum for leading activists to learn about developments in HCV treatment and access barriers, find common advocacy strategies, and meet with pharmaceutical companies about their plans for low- and middle-income countries. Click here to read the meeting report.
 

On behalf of IDSA Center for Global Health Policy, sign-on letter to support global HIV and TB funding

E-mail Print

The Center for Global Health Policy is soliciting sign-ons for a letter to members of Congress to support global HIV and TB funding. Decisions about federal funding for the fiscal year beginning October 1, 2014 will be finalized in the coming months.

Read more »
 

International Journal of Drug Policy--Call for papers on expanding access to care and treatment for HCV among people who inject drugs

E-mail Print

Outline abstracts (300 word maximum) are invited for contributions to a forthcoming special issue of The International Journal of Drug Policy on expanding access to care and treatment for hepatitis C virus (HCV) infection among people who inject drugs (PWID). Guest editors include Jason Grebely, Philip Bruggmann, Carla Treloar and Gregory Dore.

Read more »
 

AIDS Institute Webinars on Hepatitis C Testing and Treatment

E-mail Print
On July 9 and 10th, the AIDS Institute hosted two webinars on hepatitis C treatment and coverage of HCV testing under the Affordable Care Act. Click to view the slides and the webinar on the session on HCV testing. Slides from the webinar on HCV treatment are available here.
 

15th International Symposium on Viral Hepatitis and Liver Disease

E-mail Print

The 15th International Symposium on Viral Hepatitis and Liver Disease will be June 26-28, 2015 in Berlin Germany.  Visit www.isvhld2015.org for more information.

Read more »
 

AIDS 2014 Melbourne Declaration – Nobody Left Behind

E-mail Print

The Melbourne Declaration affirms that non-discrimination is fundamental to an evidence-based response to HIV and effective public health programs.

Visit www.aids2014.org/declaration.aspx to read the Melbourne Declaration and sign up to show your support. The declaration has already been signed by more than 1,100 individuals and over 100 organizations.

 

Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group

E-mail Print
In a new report published in Clinical Pharmacology & Therapeutics, Forum graduate intern Courtney Hutchison and members of the HCV Drug Development Advisory Group Steering Committee discuss the HCV DrAG as a model for public-private collaboration to accelerate drug development while highlighting its contributions to the HCV drug development field. Click here to read the report in the current issue of Clinical Pharmacology & Therapeutics
 

2015 National African American MSM Leadership Conference Early Registration Closes in 5 Weeks

E-mail Print

NAESM staff, the planning committee and participating sponsors are gearing up to present the 12th installment of the National African American MSM Leadership Conference on HIV/AIDS and other Health Disparities, scheduled to take place January 15-18, 2015 in Atlanta, GA. For more information on the conference or to register, submit an abstract or apply for a scholarship please visit the NAESM Inc. website at www.naesm.org

Read more »
 
Page 4 of 22